The Swedish CArdioPulmonary BioImage Study (SCAPIS) är ett nationellt samverkansprojekt för att reducera hjärt-kärlsjukdomar, lungssjukdomar och relaterade metabola sjukdom. Huvudmålet är att klargöra förklaringsfaktorerna till dessa sjukdomar. Forskare vid sex universitetssjukhus samarbetar i denna prospektiva observationssjudie av 30 000 slumpvis utvalda individer 50-64 år i Sverige.

SCAPIS, Swedish CArdioPulmonary bioImage Study, is a population study around cardiovascular, epidemic and genetic research, initiated by Swedish researchers in 2007. A pilot study was conducted in 2012 to ensure that the population study was possible to implement, and in …

In the longer term, we hope we can reduce the risk of disease in the heart, vessels and lungs in future generations.” Uppsala was one of six study centres that welcomed participants in SCAPIS. Region Uppsala and Uppsala University funded parts of this data collection. SCAPIS is a national project in Sweden and stands for Swedish CardioPulmonary bioImage Study. The objective of SCAPIS is to find biomarkers in order to improve the risk prediction and lower the death rate of Cardiovascular disease (CVD).

Målet är att utifrån enkla test kunna förutsäga vilka som riskerar att drabbas av hjärt-kärlsjukdomar, stroke eller KOL. SCAPIS är en befolkningsstudie där sex universitet har inkluderat totalt 30 000 slumpmässigt utvalda personer från Sverige mellan 50 och 64 år från 2013 till 2018. Syftet med SCAPIS är att kunna identifiera individuella risker för exempelvis stroke, KOL, plötsligt hjärtstopp, hjärtinfarkt och andra hjärtsjukdomar. SCAPIS - En kunskapsbank för hjärt- och lungforskning. Scapis står för Swedish CardioPulmonary bioImage Study. Studien, som Sahlgrenska Universitetssjukhuset varit drivande i, leds av en nationell forskargrupp från universiteten och universitetssjukhusen i Göteborg, Linköping, Malmö, Stockholm, Uppsala och Umeå. SCAPIS - the Largest Cardiovascular and Pulmonary Research Program in Sweden.

2021-03-17 The SCAPIS database will facilitate research on cardiovascular diseases SCAPIS. In SCAPIS (Swedish CArdioPulmonary bioImage Study) we will investigate if cadmium or lead is associated with atherosclerosis in the coronary and carotid arteries of the heart in 5000 subjects from Gothenburg. In this project we collaborate with prof Göran Bergström.

2016-12-01

Out of the original 2243, 1111 agreed to partici-pate in the SCAPIS study. Measurement of sedentary behaviour and physical activity Self-report questions The Swedish CArdioPulmonarybioImage Study (SCAPIS) combines the use of new imaging technologies, advances in large-scale omics, Swedish registers, epidemiological analysis and wellness profiling.

SCAPIS main study – preliminary data for use in local studies. The SCAPIS Pilot Study. This study was conducted in Gothenburg during 2012 and included 1111 individuals. The pilot study essentially used the same protocol as the main study, but inclusion was stratified with respect to socio-economy.

The study is led by a national team of researchers from universities and university hospitals in Gothenburg, Linköping, Malmö, Stockholm, Uppsala and Umeå. SCAPIS, funded by the Swedish Heart-Lung Foundation, enrolled more than 30,000 men and women age 50 to 64 from the general population, of whom 25,182 with no known coronary disease were imaged using coronary CT angiography. Imaging was performed at six different universities, with each doing approximately 5,000 CT angiograms. SCAPIS, Swedish CArdioPulmonary bioImage Study, är en befolkningsstudie kring kardiovaskulär, epidemisk och genetisk forskning som initierades av svenska forskare 2007. En första pilotstudie gjordes 2012 för att säkerställa att befolkningsstudien var möjlig att genomföra och 2014 startades den stora SCAPIS … SCAPIS står för Swedish CardioPulmonary bioImage Study och är ett världsunikt forskningsprojekt inom hjärta, kärl och lunga och drivs av Sahlgrenska Universitetssjukhuset, Gothia Forum och Göteborgs universitet i samarbete med Hjärt-Lungfonden. 2021-04-02 2015-05-13 The Swedish cardiopulmonary bio-image study (SCAPIS) combines the use of new imaging technologies, advances in large-scale “omics,” and epidemiological analyses to extensively characterize a Swedish cohort of 30,000 men and women aged between 50 and 64 … In 2015, a follow-up project SCAPIS – SciLifeLab Wellness Profiling was initiated with funding from KCAP to allow continuous monitoring of biomarkers after the initial base-line examination for a subset of the individuals recruited to the large SCAPIS study. The primary goal of the SCAPIS – SciLifeLab Wellness Profiling study is to develop a system for early detection of disease using continuous monitoring of … 2016-12-01 2020-11-12 "The SCAPIS study has already yielded novel data on the prevalence of coronary artery disease in the general population, and will address many critical questions over the long term," she said.

Participants were asked, The Swedish CArdioPulmonary BioImage Study (SCAPIS) included more than 30,000 men and women, ages 50-64 years, who had no history of prior heart attack or cardiac intervention. Participants were asked questions about gender, age, smoking, body measurements, cholesterol medication and blood pressure to predict their risk of coronary artery disease. CArdioPulmonary bioImage Study (SCAPIS) pilot study, conducted at the Sahlgrenska University Hospital in Göteborg, Sweden. The participants completed an extensive questionnaire regarding lifestyle and living conditions, as well as performed a submaximal cycle test to determine cardiorespiratory fitness. Participants The Swedish CardioPulmonary BioImage Study (SCAPIS) found that 40% of middle-aged adults without known heart disease had evidence of coronary atherosclerosis on coronary CT angiography (CCTA), and The study was conducted within the Swedish CArdioPulmonary BioImage Study (SCAPIS) and included 1,765 men and women aged 50-65 yr from the Linköping general population.
Visualisers for schools

Det står för Swedish Cardio Pulmonary bioImage Study. Det är ett unikt svenskt forskningsprojekt inom hjärta, kärl och lungor.

johan bertilsson fotboll
moms farmhouse restaurant
sophämtning ekerö pris
audi q7 2021
symaskin borås
sälja didner gerge

SCAPIS, the Swedish CardioPulmonary bioImage Study, är den hittills största svenska studien inom området hjärta, kärl och lunga, vilken inkluderar 30.000 män och kvinnor (50-64 år) från olika regioner i …

“The rationale for choosing this cut point is unclear as clinical risk/mortality is higher in all nonobstructive CAD than no CAD, starting at one vessel involvement,” she explained. SCAPIS, Swedish CArdioPulmonary bioImage Study, is a population study around cardiovascular, epidemic and genetic research, initiated by Swedish researchers in 2007. A pilot study was conducted in 2012 to ensure that the population study was possible to implement, and in 2014, the major SCAPIS study was initiated.

La Dra. Luna Carrillo Alemán analiza en #SECenAHA20 los resultados del estudio publicado en AHA Scientific Sessions 2020. http://lasectelleva.com

Read more about the SCAPIS study and request data access at www.scapis.org. INSAMLINGSKONTO. Plusgiro 90 91 92-7; Bankgiro 909-1927; Swish 90 91 92 7; KONTAKT. Hjärt SCAPIS, Swedish CardioPulmonary bioImage Study, planerar att omfatta 30 000 individer i åldrarna 50-64 år och är en världsunik studie som genomförs på Sahlgrenska Universitetssjukhuset och övriga fem universitetssjukhus i Sverige. Syftet är att studera hälsa inom områdena hjärta, kärl och lungor.

The Swedish CArdioPulmonary BioImage Study (SCAPIS) was initiated as a major joint national effort in Sweden to reduce mortality and morbidity from cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and related metabolic disorders, all of which are important issues for public health. This study is the first report from SCAPIS, a collaborative project between six Swedish universities with the following vision statement: to "reduce the risk of cardiovascular and respiratory SCAPIS is the largest population study in Sweden within the cardiovascular and pulmonary system area. It is a world unique project that includes 30,000 patients and involves all six healthcare regions, university hospitals and a number of scientific players. SCAPIS is designed as a prospective observational study of a randomly selected sample from the general population. The examinations were selected on the basis of their ability to provide detailed phenotypic information on subclinical disease whilst at the same time being applicable for use in a large study population.